News

Published on 18 Jun 2024 on Insider Monkey · via Yahoo Finance

Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of...


Article preview image

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this article, we are going to take a look at where Allogene Therapeutics, Inc. (NASDAQ:ALLO) stands against the other small-cap stocks.

Small-cap stocks are companies with a market capitalization of somewhere between $250 million and $2 billion. They are usually the new and the world’s up-and-coming companies.

NASDAQ.ALLO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases

The FDA clears ALLO's investigational new drug application to start clinical studies on its...

Zacks · via Yahoo Finance 29 Jan 2025

Allogene Therapeutics Inc (ALLO) Q3 2024 Earnings Call Highlights: Financial...

Allogene Therapeutics Inc (ALLO) reports a strong cash position and promising clinical progress,...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Allogene Therapeutics Inc (ALLO) Q3 2024: Everything You Need To Know Ahead Of...

Allogene Therapeutics Inc (NASDAQ:ALLO) is set to release its Q3 2024 earnings on Nov 7, 2024. Th...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Allogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In...

We recently compiled a list of the 7 Best Rising Penny Stocks To Invest In Now. In this article, ...

Insider Monkey · via Yahoo Finance 6 Oct 2024

Allogene Therapeutics, Inc. (ALLO): Short Seller Sentiment is Bearish on This...

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. ...

Insider Monkey · via Yahoo Finance 19 Sep 2024

With 56% institutional ownership, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a...

Key Insights Significantly high institutional ownership implies Allogene Therapeutics' stock pric...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of...

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates

Allogene Therapeutics (ALLO) delivered earnings and revenue surprises of 0% and 47.62%,...

Zacks · via Yahoo Finance 24 Apr 2024

How Allogene (ALLO) Stock Stands Out in a Strong Industry

One stock that might be an intriguing choice for investors right now is Allogene Therapeutics, In...

Zacks via Yahoo Finance 8 Apr 2024

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript March 14, 2024 Allogen...

Insider Monkey via Yahoo Finance 16 Mar 2024